{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:39:53Z","timestamp":1790822393577,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41429-024-00803-6","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T08:51:42Z","timestamp":1736239902000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aztreonam-avibactam: a new combination with activity against multidrug-resistant Klebsiella pneumoniae complex"],"prefix":"10.1038","volume":"78","author":[{"given":"Alicja","family":"S\u0119kowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"803_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30717-6.","volume":"13","author":"CL Gorrie","year":"2022","unstructured":"Gorrie CL, Mir\u010deta M, Wick RR, Judd LM, Lam MMC, Gomi R, et al. Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen. Nat Commun. 2022;13:3017. https:\/\/doi.org\/10.1038\/s41467-022-30717-6.","journal-title":"Nat Commun"},{"key":"803_CR2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/antibiotics11101286.","volume":"11","author":"K Xanthopoulou","year":"2022","unstructured":"Xanthopoulou K, Imirzalioglu C, Walker SV, Behnke M, Dinkelacker AG, Eisenbeis S, et al. Surveillance and genomic analysis of third-generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae complex in Germany. Antibiotics. 2022;11:1286. https:\/\/doi.org\/10.3390\/antibiotics11101286","journal-title":"Antibiotics"},{"key":"803_CR3","doi-asserted-by":"publisher","first-page":"103998.","DOI":"10.1016\/j.ebiom.2022.103998","volume":"79","author":"N Dong","year":"2022","unstructured":"Dong N, Yang X, Chan EW-C, Zhang R, Chen S. Klebsiella species: Taxonomy, hypervirulence and multidrug resistance. EBioMedicine. 2022;79:103998. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103998","journal-title":"EBioMedicine"},{"key":"803_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/mSphereDirect.00290-17","volume":"2","author":"SW Long","year":"2017","unstructured":"Long SW, Linson SE, Ojeda Saavedra M, Cantu C, Davis JJ, Brettin T, et al. Whole-genome sequencing of human clinical Klebsiella pneumoniae isolates reveals misidentification and misunderstandings of Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae. mSphere. 2017;2:e00290-17. https:\/\/doi.org\/10.1128\/mSphereDirect.00290-17","journal-title":"mSphere"},{"key":"803_CR5","doi-asserted-by":"publisher","first-page":"3000.","DOI":"10.3389\/fmicb.2018.03000","volume":"9","author":"C Rodrigues","year":"2018","unstructured":"Rodrigues C, Passet V, Rakotondrasoa A, Brisse S. Identification of Klebsiella pneumoniae, Klebsiella quasipneumoniae, Klebsiella variicola and related Phylogroups by MALDI-TOF Mass Spectrometry. Front Microbiol. 2018;9:3000. https:\/\/doi.org\/10.3389\/fmicb.2018.03000","journal-title":"Front Microbiol"},{"key":"803_CR6","unstructured":"New antibiotic to fight infections caused by multidrug-resistant bacteria | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/news\/new-antibiotic-fight-infections-caused-multidrug-resistant-bacteria (accessed April 25, 2024)."},{"key":"803_CR7","unstructured":"Surveillance Atlas of Infectious Diseases n.d. https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx (accessed March 25, 2024)."},{"key":"803_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4155\/fmc-2016-0078","volume":"8","author":"DY Wang","year":"2016","unstructured":"Wang DY, Abboud MI, Markoulides MS, Brem J, Schofield CJ. The road to avibactam: the first clinically useful non-\u03b2-lactam working somewhat like a \u03b2-lactam. Future Med Chem. 2016;8:1063\u201384. https:\/\/doi.org\/10.4155\/fmc-2016-0078","journal-title":"Future Med Chem"},{"key":"803_CR9","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/jac\/dkw231","volume":"71","author":"C Ramsey","year":"2016","unstructured":"Ramsey C, MacGowan AP. A review of the pharmacokinetics and pharmacodynamics of aztreonam. J Antimicrob Chemother. 2016;71:2704\u201312. https:\/\/doi.org\/10.1093\/jac\/dkw231","journal-title":"J Antimicrob Chemother"},{"key":"803_CR10","doi-asserted-by":"publisher","first-page":"1395.","DOI":"10.3390\/antibiotics11101395","volume":"11","author":"CH Camargo","year":"2022","unstructured":"Camargo CH, Yamada AY, de Souza AR, Reis AD, Santos MBN, de Assis DB, et al. Genomic diversity of NDM-producing Klebsiella species from Brazil, 2013\u20132022. Antibiotics. 2022;11:1395. https:\/\/doi.org\/10.3390\/antibiotics11101395","journal-title":"Antibiotics"},{"key":"803_CR11","doi-asserted-by":"publisher","first-page":"76.","DOI":"10.3390\/antibiotics12010076","volume":"12","author":"R Hatrongjit","year":"2023","unstructured":"Hatrongjit R, Chopjitt P, Boueroy P, Kerdsin A. Multiplex PCR detection of common Carbapenemase genes and identification of clinically relevant Escherichia coli and Klebsiella pneumoniae Complex. Antibiotics. 2023;12:76. https:\/\/doi.org\/10.3390\/antibiotics12010076","journal-title":"Antibiotics"},{"key":"803_CR12","unstructured":"Data from the ECDC Surveillance Atlas - Antimicrobial resistance 2017. https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-resistance\/surveillance-and-disease-data\/data-ecdc (accessed May 6, 2023)."},{"key":"803_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"803_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10096-024-04766-2","volume":"43","author":"CM Emilie","year":"2024","unstructured":"Emilie CM, Alice CM, Marine G, Farfour E, Pourbaix A, Dortet L, et al. Evaluation of the MTSTM aztreonam-avibactam strip (Liofilchem) on New Delhi metallo-\u03b2-lactamase-producing Enterobacterales. Eur J Clin Microbiol Infect Dis. 2024;43:777\u201384. https:\/\/doi.org\/10.1007\/s10096-024-04766-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"803_CR15","doi-asserted-by":"publisher","unstructured":"Huang Y-S, Chen P-Y, Chou P-C, Wang J-T. In vitro activities and inoculum effects of Cefiderocol and Aztreonam-Avibactam against Metallo-\u03b2-Lactamase-producing Enterobacteriaceae. Microbiol Spectr n.d.;11:e00569-23. https:\/\/doi.org\/10.1128\/spectrum.00569-23.","DOI":"10.1128\/spectrum.00569-23"},{"key":"803_CR16","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1128\/AAC.02019-15","volume":"59","author":"S Vasoo","year":"2015","unstructured":"Vasoo S, Cunningham SA, Cole NC, Kohner PC, Menon SR, Krause KM, et al. In vitro activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a panel of older and contemporary antimicrobial agents against Carbapenemase-producing gram-negative Bacilli. Antimicrob Agents Chemother. 2015;59:7842\u20136. https:\/\/doi.org\/10.1128\/AAC.02019-15","journal-title":"Antimicrob Agents Chemother"},{"key":"803_CR17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s10096-023-04645-2","volume":"42","author":"MG Wise","year":"2023","unstructured":"Wise MG, Karlowsky JA, Mohamed N, Kamat S, Sahm DF. In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa\/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. Eur J Clin Microbiol Infect Dis. 2023;42:1135\u201343. https:\/\/doi.org\/10.1007\/s10096-023-04645-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"803_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad032","volume":"5","author":"HS Sader","year":"2023","unstructured":"Sader HS, Castanheira M, Kimbrough JH, Kantro V, Mendes RE. Aztreonam\/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21). JAC Antimicrob Resist. 2023;5:dlad032. https:\/\/doi.org\/10.1093\/jacamr\/dlad032","journal-title":"JAC Antimicrob Resist"},{"key":"803_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/jac\/dkaa504","volume":"76","author":"HS Sader","year":"2021","unstructured":"Sader HS, Carvalhaes CG, Arends SJR, Castanheira M, Mendes RE. Aztreonam\/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019. J Antimicrob Chemother. 2021;76:659\u201366. https:\/\/doi.org\/10.1093\/jac\/dkaa504","journal-title":"J Antimicrob Chemother"},{"key":"803_CR20","doi-asserted-by":"publisher","first-page":"1591.","DOI":"10.3390\/antibiotics12111591","volume":"12","author":"D Pi\u00e9rard","year":"2023","unstructured":"Pi\u00e9rard D, Hermsen ED, Kantecki M, Arhin FF. Antimicrobial activities of Aztreonam-Avibactam and comparator agents against Enterobacterales analyzed by ICU and non-ICU wards, infection sources, and geographic regions: ATLAS Program 2016-2020. Antibiotics. 2023;12:1591. https:\/\/doi.org\/10.3390\/antibiotics12111591","journal-title":"Antibiotics"},{"key":"803_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04873-22","volume":"11","author":"J Chen","year":"2023","unstructured":"Chen J, Liu Y, Jia W, Xu X, Sun G, Wang T, et al. In vitro activities of Aztreonam-Avibactam, Eravacycline, Cefoselis, and other comparators against clinical Enterobacterales Isolates: a Multicenter Study in China, 2019. Microbiology Spectrum. 2023;11:e04873-22. https:\/\/doi.org\/10.1128\/spectrum.04873-22","journal-title":"Microbiology Spectrum"},{"key":"803_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02806-23","volume":"11","author":"D Li","year":"2023","unstructured":"Li D, Yu H, Huang X, Long S, Zhang J. In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates. Microbiol Spectr. 2023;11:e0280623. https:\/\/doi.org\/10.1128\/spectrum.02806-23","journal-title":"Microbiol Spectr"},{"key":"803_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jgar.2022.06.018","volume":"30","author":"GM Rossolini","year":"2022","unstructured":"Rossolini GM, Stone G, Kantecki M, Arhin FF. In vitro activity of aztreonam\/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019. J Glob Antimicrob Resist. 2022;30:214\u201321. https:\/\/doi.org\/10.1016\/j.jgar.2022.06.018","journal-title":"J Glob Antimicrob Resist"},{"key":"803_CR24","doi-asserted-by":"publisher","unstructured":"Ageevets V, Sulian O, Avdeeva A, Chulkova P, Ageevets I, Gostev V, et al. Minimum inhibitory concentrations of aztreonam\u2013avibactam, ceftazidime\u2013avibactam and meropenem in clinical isolates of Klebsiella pneumoniae harboring carbapenemase genes. J Antibiot 2024:1\u20135. https:\/\/doi.org\/10.1038\/s41429-024-00758-8.","DOI":"10.1038\/s41429-024-00758-8"},{"key":"803_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jac\/dkz468","volume":"75","author":"S Niu","year":"2020","unstructured":"Niu S, Wei J, Zou C, Chavda KD, Lv J, Zhang H, et al. In vitro selection of aztreonam\/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2020;75:559\u201365. https:\/\/doi.org\/10.1093\/jac\/dkz468","journal-title":"J Antimicrob Chemother"},{"key":"803_CR26","doi-asserted-by":"publisher","unstructured":"Sader HS, Mendes RE, Pfaller MA, Shortridge D, Flamm RK, Castanheira M. Antimicrobial activities of Aztreonam-Avibactam and comparator agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates. Antimicrob Agents Chemother 2017;62. https:\/\/doi.org\/10.1128\/aac.01856-17.","DOI":"10.1128\/aac.01856-17"},{"key":"803_CR27","doi-asserted-by":"publisher","unstructured":"Nordmann P, Yao Y, Falgenhauer L, Sadek M, Imirzalioglu C, Chakraborty T. Recent emergence of Aztreonam-Avibactam resistance in NDM and OXA-48 Carbapenemase-Producing Escherichia coli in Germany. Antimicrob Agents Chemother 2021;65:https:\/\/doi.org\/10.1128\/aac.01090-21.","DOI":"10.1128\/aac.01090-21"},{"key":"803_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbac029","volume":"5","author":"S Wu","year":"2022","unstructured":"Wu S, Zong Z. Aztreonam-avibactam: an option against carbapenem-resistant Enterobacterales with emerging resistance. Precis Clin Med. 2022;5:pbac029 https:\/\/doi.org\/10.1093\/pcmedi\/pbac029","journal-title":"Precis Clin Med"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00803-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T23:03:05Z","timestamp":1740610985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00803-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1038\/s41429-024-00803-6","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Bioethical Commission of Nicolaus Copernicus University, Torun The Ludwik Rydygiers Collegium Medicum, Bydgoszcz (No. 270\/2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}